Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis

Pyne, A. L., Uchida, A. M., Hazel, M. W., Stubben, C. J., Chang, J. W., Bailey, D. D., Gonsalves, N., Allen-Brady, K., Peterson, K. A., & Pletneva, M. A. (2024). Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae031

Authors:

Ashley L Pyne

Amiko M Uchida

Mark W Hazel

Chris J Stubben

Joy W Chang

Dominique D Bailey

Nirmala Gonsalves

Kristina Allen-Brady

Kathryn A Peterson

Maria A Pletneva

Affiliated Authors: